Literature DB >> 10601542

Sensitivity and limitations of high throughput fluorescent microsatellite analysis for the detection of allelic imbalance: application in lung tumors.

T Liloglou1, P Maloney, G Xinarianos, S Fear, J K Field.   

Abstract

We have used two hexaplex fluorescent microsatellite assays and analysis on an automatic sequencer to determine allelic imbalance in lung tumors. The markers used are located close to tumor-suppressor genes, DNA repair genes and regions frequently lost in lung cancer. We present a reference interval and quantify the reproducibility of the assays as assessed by multiple repeat reactions for normal DNAs. The cut-off value was calculated to 0.77 (23% reduction of one allele intensity) which, to the best of our knowledge, is currently the lowest reported cut-off. Using these parameters we analysed 85 lung carcinomas. Eighty-three samples (97.6%) showed allelic imbalance in at least one locus. It is of note that by using a selection of only 6 markers, imbalance was detected in 81 (95.2%) of the samples. Loci 9p21 and 9p23 exhibited the greatest imbalance (77% and 75% respectively). The fractional allele loss (FAL) for the 3p markers examined was greater in squamous cell carcinomas than adenocarcinomas (t-test, p=0.0001) while no such difference was observed for 9p. The degree of imbalance of different markers within the same sample was divergent, indicating heterogeneity of genomic status (losses, amplifications, aneuploidy) in these tumors. In conclusion, we have established a robust experimental platform with high throughput, sensitivity and specificity for the detection of allelic imbalance in lung tumors. Such assays may be useful for the detection of allelic imbalance in clinical samples to trace genetically abnormal cells and thus assist in the identification of individuals at a high risk for developing lung cancer.

Entities:  

Mesh:

Year:  2000        PMID: 10601542     DOI: 10.3892/ijo.16.1.5

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  4 in total

1.  Loss of heterozygosity studies revisited: prior quantification of the amplifiable DNA content of archival samples improves efficiency and reliability.

Authors:  Kathryn Farrand; Lydija Jovanovic; Brett Delahunt; Bryan McIver; Ian D Hay; Norman L Eberhardt; Stefan K G Grebe
Journal:  J Mol Diagn       Date:  2002-08       Impact factor: 5.568

2.  METH-2 silencing and promoter hypermethylation in NSCLC.

Authors:  J R Dunn; D Panutsopulos; M W Shaw; J Heighway; R Dormer; E N Salmo; S G Watson; J K Field; T Liloglou
Journal:  Br J Cancer       Date:  2004-09-13       Impact factor: 7.640

3.  Overexpression of aurora B kinase (AURKB) in primary non-small cell lung carcinoma is frequent, generally driven from one allele, and correlates with the level of genetic instability.

Authors:  S L Smith; N L Bowers; D C Betticher; O Gautschi; D Ratschiller; P R Hoban; R Booton; M F Santibáñez-Koref; J Heighway
Journal:  Br J Cancer       Date:  2005-09-19       Impact factor: 7.640

4.  Mutational analysis of cytocentrifugation supernatant fluid from pancreatic solid mass lesions.

Authors:  Sydney D Finkelstein; Marluce Bibbo; Thomas E Kowalski; David E Loren; Ali A Siddiqui; Charalambos Solomides; Eric Ellsworth
Journal:  Diagn Cytopathol       Date:  2013-11-22       Impact factor: 1.582

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.